ML Arrhythmia Risk Prediction from Normal Cardiac Signals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac monitors (ICMs) and other medical devices lack the ability to predict future arrhythmia episodes based on normal/physiologic electrogram (EGM) signals, failing to provide timely life-saving interventions for patients at risk.
Innovation Solution
A system utilizing a machine learning model, specifically a convolutional neural network, is employed to analyze cardiac activity signals and identify risk factors for arrhythmias, even when the signals exhibit physiologic behavior, by converting actual signals into pseudo signals to simulate different electrode configurations, enabling prediction of arrhythmia occurrence and severity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional arrhythmia detection algorithms are used to analyze cardiac activity signals, then the device can detect arrhythmias based on non-physiologic characteristics, but it cannot predict future arrhythmia episodes from normal/physiologic signals
Solution Approach 1:
A machine learning model serves as an intermediary between traditional detection algorithms and prediction outcomes. The ML model processes normal cardiac activity signals and extracts subtle patterns that traditional algorithms miss, converting physiologic signals into predictive information about future arrhythmia risk without requiring non-physiologic characteristics.
Solution Approach 2:
The system performs preliminary analysis of cardiac signals during normal physiologic states to identify risk factors before arrhythmia occurs. By continuously analyzing normal signals and comparing them against trained models, the system prepares predictions in advance, enabling early warning of potential arrhythmia episodes before actual non-physiologic patterns emerge.
2Measurement precision
If implantable cardiac monitors store and analyze cardiac activity strips for long periods, then they can identify arrhythmia patterns, but they cannot determine risk factors from normal signals without actual arrhythmia episodes
Solution Approach 1:
The machine learning model incorporates feedback loops that continuously refine risk predictions based on incoming cardiac signals. As new normal signals are collected and analyzed, the model updates risk factor assessments in real-time, improving measurement precision progressively. This feedback mechanism allows the system to learn from accumulating normal signal data without requiring waiting for actual arrhythmia episodes.
Solution Approach 2:
The system performs preliminary risk stratification by analyzing normal cardiac signals and comparing them against patterns learned during training phases. This preliminary assessment provides early risk indicators before arrhythmia occurs, reducing the time loss between signal collection and actionable prediction by preparing risk assessments in advance based on normal signal characteristics.
3Object-affected harmful factors
If ICMs are used instead of ICDs in patients without prior indications, then clinical risks and costs are reduced, but the ability to provide life-saving therapy is lost
Solution Approach 1:
The machine learning model performs preliminary identification of patients at high risk for future arrhythmia by analyzing normal cardiac signals. This preliminary risk stratification allows clinicians to proactively identify patients who would benefit from ICD implantation before an actual arrhythmia event occurs, enabling preventive therapy placement that reduces both long-term clinical risk and potential costs by avoiding emergency interventions.
Solution Approach 2:
The system provides continuous feedback on predicted arrhythmia risk levels, allowing dynamic adjustment of monitoring and treatment strategies. When the ML model predicts elevated risk factors from normal signals, the system can trigger enhanced monitoring or clinical review, ensuring that life-saving therapy availability is maintained through proactive risk management while still allowing ICM use in low-risk patients to reduce unnecessary clinical risks and costs.
Data Source
AI summary
A system and method for determining an arrhythmia risk are provided and include memory to store specific executable instructions and a machine learning (ML) model trained to predict an arrhythmia with a characteristic of interest (COI) that exhibits a non-physiologic behavior. One or more processors are configured to execute the specific executable instructions to obtain CA signals collected by an implantable medical device (IMD), wherein the COI exhibits a physiologic behavior and apply the ML model to the CA signals to identify a risk factor that a patient will experience the arrhythmia at a future point in time even though the COI in the CA signals, exhibits a physiologic behavior.